Discovering a drug and testing its efficacy are two major steps in the process of getting a treatment to patients.
Biomanufacturing addresses the next stage of drug commercialization. When a drug has been approved, companies rely on biomanufacturing facilities to reliably produce and commercially scale the product for distribution.
By creating these facilities in the same region where drug discovery begins, companies can remove many of the bottlenecks that outsourcing can create.
BioConnects New England is focused on creating equity and economic growth through opportunity and existing resources. The coalition’s goal of coupling biomanufacturing facilities with the area’s well-established and internationally-known biotech sector will provide the infrastructure needed to grow the industry beyond its current footprint and provide jobs and opportunities for communities often overlooked or ignored.
All content © BioConnects New England
